Public opinion on global rollout of COVID-19 vaccines

Clarke, Philip; Roope, Laurence; Loewen, Peter John; Bonnefon, Jean‐François; Melegaro, Alessia; Friedman, Jorge; Violato, Mara; Barnett, Adrian; Duch, Raymond M.

doi:10.1038/s41591-021-01322-9

Cited by 32 publications

(42 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… ‡‡ In related work that analyzes this 13-country survey, we also find what appears to be altruistic attitudes regarding vaccine allocations. It is interesting to note that we find that a majority of respondents from the developed economies in our sample expressed support for donating at least 10% of their vaccine supplies to countries in need ( 35 ). …”

mentioning

confidence: 83%

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Duch

Roope

Violato

et al. 2021

Proc. Natl. Acad. Sci. U.S.A.

Self Cite

View full text Add to dashboard Cite

How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.

show abstract

mentioning

confidence: 83%

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Duch

Roope

Violato

et al. 2021

Proc. Natl. Acad. Sci. U.S.A.

Self Cite

View full text Add to dashboard Cite

show abstract

“…2 , 3 However, notwithstanding compelling arguments, the willingness of HIC governments to make sufficient COVID-19 vaccine doses available to LICs is likely to hinge largely on the extent to which the general public are supportive. In recent online survey work, we provided evidence of strong public support for donations to LICs that was consistent across seven HICs [ 12 ]. We documented evidence that, in each country, between 48% and 56% supported some level of donation of vaccine doses [ 12 ].…”

Section: Introductionmentioning

confidence: 95%

“…In recent online survey work, we provided evidence of strong public support for donations to LICs that was consistent across seven HICs [ 12 ]. We documented evidence that, in each country, between 48% and 56% supported some level of donation of vaccine doses [ 12 ]. Moreover, of those who supported vaccine donations, over 70% favoured donating at least 10% of their country’s doses [ 12 ].…”

Section: Introductionmentioning

confidence: 95%

Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries

Roope

Barnett

Candio

et al. 2021

Appl Health Econ Health Policy

Self Cite

View full text Add to dashboard Cite

“…The most comprehensive study on public opinion about the global rollout of COVID-19 vaccines 25 surveyed 8209 participants from Australia, Canada, France, Italy, Spain, UK and US. They found that most agreed with the principle that allocation be based on need and were in favour of donation, while allocation based on the country in which vaccines were developed was least popular.…”

Section: Introductionmentioning

confidence: 99%

Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom

et al. 2021

View full text Add to dashboard Cite

BackgroundVaccine nationalism has become a key topic of discussion during the development, testing, and rollout of COVID-19 vaccines. Media attention has highlighted the ways that global, coordinated access to vaccines has been limited during the pandemic. It has also exposed how some countries have secured vaccine supply, through bilateral purchase agreements and the way pharmaceutical companies have priced, negotiated, and delivered these supplies. Much of the focus of this debate has been on the vaccine supply ‘winners’ and ‘losers’, but the voices of public opinion have been more limited.MethodsWe explore the concepts of vaccine nationalism and internationalism from the perspective of vaccine trial participants, using an empirical perspectives study that involved interviews with phase I/II COVID-19 vaccine trial participants in Oxford, UK. We surveyed and interviewed participants between September and October 2020 about their views, motivations and experiences in taking part in the trial.ResultsFirst, we show how trial participants describe national and international ideas about vaccination as intertwined and challenge claims that these positions are mutually exclusive or oppositional. Second, we analyse these viewpoints further to show that vaccine nationalism is closely connected with national pride and metaphors of a country’s scientific achievements. Participants held a global outlook and were highly supportive of the prioritisation of vaccines by global need, but many were also pessimistic that such a solution could be possible.ConclusionTrial participants constitute an informed public group, with situated public expertise that the global community could draw on as an expert opinion. We argue that vaccine nationalism is strongly attached to national character and, therefore, it is more difficult for ownership of a vaccine to be though of as international.

show abstract

Public opinion on global rollout of COVID-19 vaccines

Cited by 32 publications

References 6 publications

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries

Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom

Contact Info

Product

Resources

About